← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2007Last known activity
Jan 31, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT02976688Lead sponsorPhase 2/Phase 3Jan 31, 2017
- NCT02976688Reponsible party - principal investigatorPhase 2/Phase 3Jan 31, 2017
- NCT02976688Sponsor investigatorPhase 2/Phase 3Jan 31, 2017
- NCT01640119Overall official - principal investigatorPhase 3Jul 1, 2014
- NCT01640119Lead sponsorPhase 3Jul 1, 2014
- NCT01640119Reponsible party - principal investigatorPhase 3Jul 1, 2014
- NCT00710788Lead sponsorN/AJan 1, 2007
- NCT00710788Reponsible party - principal investigatorN/AJan 1, 2007
Details
- Last known activity
- Jan 31, 2017